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Abstract
Patients with coarctation of the aorta (CoA) are prone to morbidity including atherosclerotic
plaque that has been shown to correlate with altered wall shear stress (WSS) in the descending
thoracic aorta (dAo). We created the first patient-specific computational fluid dynamics (CFD)
model of a CoA patient treated by Palmaz stenting to date, and compared resulting WSS
distributions to those from virtual implantation of GenesisXD and modified NumedCP stents also
commonly used for CoA. CFD models were created from magnetic resonance imaging,
fluoroscopy and blood pressure (BP) data. Simulations incorporated vessel deformation,
downstream vascular resistance and compliance to match measured data and generate blood flow
velocity and time-averaged WSS (TAWSS) results. TAWSS was quantified longitudinally and
circumferentially in the stented region and dAo. While modest differences were seen in the distal
portion of the stented region, marked differences were observed downstream along the posterior
dAo and depended on stent type. The GenesisXD model had the least area of TAWSS values
exceeding the threshold for platelet aggregation in vitro, followed by the Palmaz and NumedCP
stents. Alterations in local blood flow patterns and WSS imparted on the dAo appear to depend on
the type of stent implanted for CoA. Following confirmation in larger studies, these findings may
aid pediatric interventional cardiologists in selecting the most appropriate stent for each patient,
and ultimately reduce long-term morbidity following treatment for CoA by stenting.
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INTRODUCTION
Coarctation of the aorta (CoA) is characterized by a stenosis of the proximal descending
thoracic aorta and is one of the most common congenital heart defects (8–11%) affecting
5,000 to 8,000 births annually in the United States[13,5]. While surgical therapy has long
been the mainstay of treatment, the less invasive nature, shorter hospitalization, reduced pain
and decreased cost of catheter-based therapies has led to them playing an increasing
role[30]. In particular, stents have become a popular choice for their ability to cause less
trauma and resist recoarctation more effectively relative to balloon angioplasty.
Since the first clinical use of stents for CoA in 1991, numerous reports have shown their
ability to successfully reduce the pressure gradient across a coarctation and generally restore
the aorta to normal caliber[11,21,27,28]. Although stents with various designs may satisfy
these criteria for success, the geometry of stents used in other vascular beds is known to
influence local flow disturbances[19,24,35] including indices of wall shear stress (WSS,
defined as the tangential force per unit area exerted on a blood vessel wall as a result of
flowing blood). Interestingly, in a study of ten middle-aged adults with pre-existing plaques,
areas of low time-averaged WSS (TAWSS) were found in a rotating pattern progressing
down the descending thoracic aorta (dAo) and correlated with areas of atherosclerosis[34].
Other studies have indicated excessively high WSS can also be deleterious by initiating
platelet aggregation[12]. Thus, geometric intricacies of the particular stent used to treat CoA
may uniquely influence the likelihood and severity of future dAo pathology. Stent-induced
local flow alterations may also be accentuated in cases of residual narrowing where even a
modest reduction in diameter within the coarctation region can accelerate blood through the
stent and further contribute to deleterious downstream flow alterations. No studies to date
have characterized local WSS after stenting for CoA.
Computational fluid dynamics (CFD) enables detailed spatiotemporal quantification of
hemodynamic indices including WSS based on magnetic resonance imaging (MRI) and
blood pressure (BP) data. CFD also facilitates virtual treatment of CoA for comparison of
hemodynamic alterations between stents in the same vessel[10]. The objective of the current
investigation was to create the first patient-specific CFD model of a patient treated for CoA
by stenting, and compare distributions of WSS to those resulting from virtual implantation
of two other stents commonly used to treat CoA.
MATERIALS AND METHODS
A CFD model of the vasculature was created by converting medical imaging data into a
geometrically representative computer model[36]. MRI was performed for a 15 year old
patient previously treated for CoA by Palmaz stent placement (Cordis Corp., Miami Lakes,
FL) as part of a clinically ordered imaging session and after IRB approval facilitating use of
the data for computational modeling. Gadolinium-enhanced magnetic resonance
angiography (MRA) and phase contrast MRI (PC-MRI) were conducted to delineate
vascular morphology[20,36] and calculate time-resolved volumetric blood flow[17],
respectively. Upper extremity supine systolic, mean and diastolic BP values of 113, 85 and
64 mmHg, respectively, were measured using an automated sphygmometer cuff.
MRA data was processed for gradient nonlinearities[2] before CFD models were constructed
using the SimVascular software package (https://simtk.org)[36]. Magnetic field
inhomogeneities from the stent caused signal dropout in the volumetric MRA data (Figure
1A). Fluoroscopic angiography data from the same time period (Figure 1B) was therefore
used to extract the dimensions and positioning of the stent within the coarctation region (e.g.
average diameter in stented region 12 mm). Geometric characteristics (Table 1) of the
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implanted and two additional stents, a modified Numed Cheatham Platinum (Hopkinton,
NY) with rectangular, as compared to circular, struts and a Genesis XD (Cordis Corp.), were
obtained from literature[4,7]. These stents were created using computer aided design
software (Solidworks Corp., Concord, MA). Each was then virtually implanted into a
separate, but otherwise equivalent, CFD model of the patient's thoracic aorta before stenting
(Figure 2) using the methods described by Gundert et al[10]. It was assumed that no portion
of the stent's thickness was embedded in the aortic wall immediately after implantation since
data was not available on the potentially differing amounts of strut thickness recessed into
the aortic wall for each stent. Models were discretized using a commercially available,
automatic mesh generation program (MeshSim, Simmetrix, Clifton Park, NY). Meshes were
refined using an adaptive method[23,29] to automatically allocate elements based on the
complexity of local flow patterns outside the stented region and reduce computational cost
as compared to isotropic meshes. The size of elements near stent struts and the vessel wall
were explicitly defined to adequately resolve flow features throughout the stent (Figure 3,
Supporting Information). Simulations incorporating aortic deformation[6,17], downstream
vascular resistance and compliance[32,31] were performed using a novel stabilized finite
element method to solve the conservation of mass (continuity), balance of fluid momentum
(Navier-Stokes) and vessel wall elastodynamics equations[6] until flow rate and BP fields
were periodic and matched measured data.
Results for TAWSS within the stented region and the dAo distal to the stent were quantified
by unwrapping the surface geometry of the vessel at the inner curvature[16,33]. TAWSS
values were then plotted circumferentially for the proximal and distal regions of the stent as
well as four locations along the dAo. TAWSS values were also plotted longitudinally along
regions of particular interest within the dAo. To further delineate local differences in
TAWSS due to stent type, the area of the dAo exposed to a high TAWSS threshold of 50
dyne/cm2 (at which platelet aggregation occurs in vitro[12]) was quantified.
RESULTS
TAWSS values >100 dyn/cm2 were observed within the proximal portion of the stented
region and in the dAo 10 mm to 110 mm distal to the stent, with varying severity depending
on stent type (Figure 4). The Palmaz stent showed two focal regions of elevated TAWSS in
the dAo. The first initiated along the outer right luminal surface ~10 mm distal to the stent
and extended to the center and then the outer left surface over ~40 mm. The second was
located 75–100 mm distal to the stent along the outer right luminal surface. The NumedCP
stent also displayed two focal regions of elevated TAWSS along the outer left and right
luminal surfaces ~30 to 70 mm distal to the stent. In contrast, the GenesisXD stent displayed
a single focal region of elevated TAWSS along center of the outer luminal surface from ~10
to 20 mm distal to the stent. The lowest TAWSS values (<25 dyn/cm2) appeared within the
distal stented region and along the inner curvature of the proximal dAo 0 to 50 mm
downstream regardless of the type of stent implanted.
Circumferential quantification revealed higher TAWSS along the outer portion of the
stented region (Figure 4, locations 1 and 2), while TAWSS along the inner curvature did not
exceed 20 dyn/cm2. Differences in TAWSS were more pronounced in the distal versus the
proximal stented region. For example, TAWSS peaked at ~ 80 dyn/cm2 in the distal region
of the GenesisXD simulation as compared to values >80 dyn/cm2 throughout the entire
proximal stented region. The Palmaz stent had the lowest value of peak TAWSS in the distal
region (51.7 dyn/cm2) as compared to NumedCP (80.0 dyn/cm2) and GenesisXD (82.4 dyn/
cm2). The region with elevated TAWSS ~15 mm distal to the stent (Figure 4, location 3)
was also quantified circumferentially. Spatial distributions of TAWSS were similar among
stents with highest values along the outer curvature (peak TAWSS of 95.7, 82.6 and 121
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dyn/cm2 for Palmaz, NumedCP and GenesisXD, respectively) and low TAWSS values <25
dyn/cm2. Peak TAWSS ~45 mm distal to the stent (Figure 4, location 4) was located along
the left outer luminal surface of the dAo for Palmaz and NumedCP (90.5 and 139 dyn/
cm2respectively), while the GenesisXD had a more uniform TAWSS distribution with a
peak value of 64.8 dyn/cm2 along the outer curvature.
Longitudinal quantification was additionally performed along regions of the dAo distal to
the stent with elevated TAWSS. Distributions of TAWSS along the outer left luminal
surface for NumedCP and Palmaz stents (Figure 4, location 5) were elevated between 20
mm and 110 mm with peak values of 168 and 110 dyn/cm2 as compared to 49.3 dyn/cm2 for
the GenesisXD. Differences in TAWSS along the right outer luminal surface (Figure 4,
location 6) were less pronounced between stents with values for GenesisXD generally lower
than others.
Figure 5 shows the area of TAWSS in the dAo exceeding the threshold for platelet
aggregation in vitro[12]. The GenesisXD model had the least area of TAWSS above the
threshold (Table 2) followed by the Palmaz and NumedCP stents.
DISCUSSION
The objective of this investigation was to create the first patient-specific CFD model of a
patient treated for CoA by stenting, and compare distributions of WSS in the stent and dAo
to those from virtual implantation of two other stents commonly used to treat CoA. This
objective was motivated by stents playing an increasing role in the treatment of CoA. The
results illustrate how CFD can provide useful insight and potentially scrutinize stent
performance in a retrospective or prospective manner.
The main finding of this investigation is that alterations in local flow patterns and WSS
imparted on the thoracic aorta in patients treated for CoA may uniquely depend on the type
of stent implanted. While modest differences were seen in the distal portion of the stented
region, marked differences were observed downstream along the posterior surface of the
dAo. It is important to note that the methods applied with CFD models were carefully
controlled to isolate the influence of stent design. The overall vessel geometry, including
residual narrowing in the stented region, was consistent between simulations. Inlet and
outlet boundary conditions were also consistent for all models, resulting in <0.3% difference
in the distribution of flow to the dAo between simulations for each stent type. An analysis of
mesh independence (Supporting Information) confirmed differences were not due to aspects
of the computational meshes used for each simulation.
The current results indicate adverse local flow alterations were least severe for the
GenesisXD, for which regions of elevated TAWSS and variability at the specific locations
quantified were smallest. In contrast, the Palmaz and NumedCP stents both exhibited a
greater percentage of high TAWSS along the posterior dAo. These differences are likely
rooted in the design attributes of each stent. Attributes including strut thickness, proximity,
angle relative to the primary flow direction, and ratio of stent-to-vessel area were predictive
of adverse distributions of WSS in prior studies[24,3,18]. Since all stent struts disturb local
flow patterns, thicker struts protrude further into the flow domain and increase the severity
of these disturbances. Similarly, the relative ratio of stent-to-vessel area influences the total
amount of the vessel wall exposed to potentially deleterious flow patterns. The angle of
struts relative to the primary direction of fluid flow, together with the overall stent geometry,
can also influence the severity of flow disturbances caused by a stent. Stents with their
linkages primarily arranged longitudinally have the potential to cause less severe flow
disruptions as compared to ring-and-link designs primarily arranged circumferentially. For
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example, when stents are expanded to larger diameters, as can occur with redilation for
recurrent CoA, their overall linkage design becomes arranged in a less longitudinal manner
causing adjacent layers of fluid to be redirected more abruptly as they pass through the
stented region. In contrast, larger intrastrut regions aligned in the primary direction of fluid
flow limit separation and stagnation between struts. The Palmaz stent modeled in the current
investigation with the greatest strut thickness and width, number of circumferential and
longitudinal repeating units, and ratio of stent-to-vessel area showed two focal regions of
elevated TAWSS in the downstream dAo. The NumedCP stent with larger intrastrut area
and only slightly thinner struts also displayed two focal regions of elevated TAWSS along
the dAo. In contrast, the GenesisXD stent with the thinnest struts, large intrastrut regions,
and ratio of stent-to-vessel area similar to the NumedCP stent displayed a single focal region
of elevated TAWSS downstream of the stent.
An analysis of Reynolds numbers may further explain the current results. The Reynolds
number (Re) is a dimensionless parameter describing the ratio of convective inertial forces
to viscous forces. In general, values <2,000 constitute laminar flow where adjacent layers of
fluid move in layers without mixing, while those >2,000 may be characterized as transitional
or turbulent depending on specific details of the local flow domain. Mean and peak Re in the
dAo for the patient studied here were ~1,750 and 5,300, respectively. These Re suggest flow
was generally laminar throughout the cardiac cycle, but there were undoubtedly portions
during which flow was transitional or turbulent. During these times modest differences in
local vessel geometry caused by design attributes of a particular stent could cause
perturbations resulting in irregular erratic intermingling of fluid particles downstream of the
stent and manifest in the differences observed.
The current results may have important clinical implications as low TAWSS values are
associated with the onset and progression of cardiovascular disease in many vascular
beds[37], and TAWSS above a certain preferential value may be associated endothelial
injury, plaque rupture, or thrombogenesis[14,15]. For example, a previous study of healthy
young adults found areas of adverse WSS in a rotating pattern progressing down the dAo[8].
A second previous study of ten middle-aged adults with pre-existing plaques revealed
similar WSS patterns that correlated with areas of atherosclerosis[34]. When joined with the
current results, the collective findings suggest the type of stent used to treat CoA may
uniquely influence the future location and severity of aortic plaque. This may be of
particular importance for CoA patients since their stents are often implanted at a younger
age than adults receiving stents for the treatment of acquired cardiovascular disease. In
addition to vascular remodeling processes triggered by indices of WSS[9], local velocity jets
and accompanying high TAWSS values imparted on the posterior wall due to a particular
stent type may lead to tortuosity as seen in a rabbit model of CoA[22], or disturb the
cushioning function of the thoracic aorta by increasing stiffness[25]. However, these
hypotheses remain to be tested in a follow-up study.
While there are many publications quantifying outcomes from stenting as compared to
surgery or balloon angioplasty, most of these studies have grouped outcomes from several
stents together thereby resulting in a paucity of data comparing one stent type to another for
metrics beyond stent fracture. To our knowledge, this is the first investigation to incorporate
realistic stent geometries into an entire thoracic aortic CFD model in order to quantify the
impact of stent design on local hemodynamic alterations. While previous CFD studies
involving stenting of the thoracic aorta provided invaluable information, they often included
limitations such as omitting detailed geometric intricacies of a stent, used models restricted
to the stented region, or did not include analysis of downstream hemodynamic alterations.
The current investigation strongly suggests these downstream hemodynamic alterations
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unique to a given stent may be an important factor contributing to mechanical stimuli, and
likely influencing vascular remodeling or plaque formation, after treatment for CoA.
The current results also extend the body of literature using CFD to study treatments for CoA
by quantifying TAWSS alterations due to stent design. Previously Coogan et al. used a
patient-specific CFD model of the thoracic aorta to study compliance mismatch created by
making a portion of the dAo rigid, which had only a modest impact on cardiac work and
BP[1]. The current results can also be appreciated relative to those from CFD models of
untreated (i.e. native) CoA patients and those corrected by end-to-end or end-to-side repair
that used equivalent CFD methods[17]. The range of TAWSS in the dAo here are below the
values observed with untreated patients in the prior study (1,777–6,000 dyn/cm2), but were
still more severe than those observed with surgically corrected or normal patients in the
prior study.
The current study should be interpreted relative to other sources of morbidity in CoA, such
as hypertension, and with the constraints of several potential limitations. The strut cross
section of the virtually implanted NumedCP was rectangular, rather than circular, due to
restrictions with the virtual stenting process. The use of a NumedCP stent with circular struts
would likely decrease the severity of downstream hemodynamic alterations shown here.
Future studies will strive to incorporate this realism. The prolapse of tissue into intrastrut
regions was not considered here since the main focus was to quantify hemodynamic
alterations downstream of the stented region and isolate the impact of different stent designs.
Nevertheless, this factor should also be considered in future studies, perhaps using the
approach Murphy el al. applied in CFD models of a stented coronary artery[24].
Results presented correspond to the acute period after stenting. Prior studies linking WSS
distributions with future plaque locations suggest the distributions created by a given stent
during the acute period are important as they establish the severity of mechanical stimuli for
potential cellular proliferation. Nonetheless, these distributions of WSS will change over
time so future studies are necessary to characterize chronic WSS distributions occurring in
response to geometric changes from neointimal or somatic growth.
Detailed patterns of TAWSS shown here were influenced by stent type, are also largely
dictated by vessel morphology and flow distributions to the head and neck arteries. For
example, the presence of elevated TAWSS in the proximal stented region was a function of
patient arch morphology and may not have been present in a patient with a gothic or crenel
arch[26]. The current results would likely be altered by different arch morphologies, surgical
corrections or other stent types. By applying knowledge gained from prior studies it may be
possible to use the current techniques to predict outcomes for a variety of interventions.
Future work should be conducted with patients undergoing treatment of CoA using different
stents before CFD results are used to recommend a specific stent for a given patient. The
current investigation demonstrates that the type of stent implanted can influence TAWSS
distributions, which may be further accentuated or mitigated depending on a given patient's
aortic morphology.
CONCLUSION
In summary, the current study is the first to quantify downstream hemodynamic alterations
due to stenting in CoA patients using patient-specific CFD models with virtually implanted
stents. The current results showed marked differences in TAWSS patterns in the
downstream dAo depending on the stent implanted. Following confirmation with future
studies containing more patients, these findings may aid pediatric interventional
cardiologists in determining which models to stock within the cath lab, selecting the most
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appropriate stent for each patient, elucidating favorable attributes for next-generation
designs that optimize downstream flow disturbances, and reducing long-term morbidity
following treatment for CoA by stenting.
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Figure 1.
Rendering of magnetic resonance imaging (MRI) data (A) and an angiographic image of the
same patient obtained by fluoroscopy (B). CFD models were constructed using the MRI data
with diameters of the stented region extracted from the fluoroscopy data to account for
signal dropout created by artifacts due to the implanted Palmaz stent.
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Figure 2.
Palmaz (left), NumedCP (middle) and GenesisXD (right) stents created using computer
aided design software (top row). These stents were then subtracted from copies of the same
patient-specific computational model to produce the flow domain associated with each stent
(bottom row).
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Figure 3.
Example illustrating the meshing approach for the stented region. An adaptive meshing
process created elements of appropriate size in proximal intrastrut regions (A, top images),
but regions of low velocity adjacent to stents struts and the distal portion of the stented
region contained fewer and larger elements after the adaptive process. The minimum edge
size of all elements within the proximal stented region after adapting was therefore
determined and explicitly applied within the stented region to generate meshes containing
~8.3 million elements (B, bottom images).
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Figure 4.
Distributions of time-averaged wall shear stress for the Palmaz, NumedCP, and GenesisXD
stents. CFD results for the full model are shown next to spatial maps that have been
unwrapped about the outer (posterior) surface for the stented region and the distal
descending aorta. Circumferential and longitudinal plots are also shown at several locations:
proximal stented region (1), distal stented region (2), 15 mm distal to the stent (3), 45 mm
distal to the stent (4), as well as the left (5) and right (6) portions of the outer curvature. Note
that values occurring atop stent struts have been removed to improve the legibility of plots.
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Figure 5.
Locations of elevated time-averaged wall shear stress for the Palmaz, NumedCP, and
GenesisXD stents. The full CFD model results are shown next to spatial maps that have
been unwrapped about the outer (posterior) surface for the descending aorta distal to the
stent. Regions with time-averaged wall shear stress above 50 dyn/cm2 have been made
opaque. Values above this threshold have been previously correlated with platelet
aggregation.
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Table 1
Design attributes of stents virtually implanted for CoA
Palmaz NumedCP GenesisXD
Thickness (mm) 0.312 0.254 0.173
Strut width (mm) 0.338 0.3 0.205 (macro)
0.123 (micro)
Number of circumferential repeating units 14 8 11
Number of longitudinal repeating units 7 6 5
Stent/Vessel contact area (mm2) 243 128 106
Pediatr Cardiol. Author manuscript; available in PMC 2015 April 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Kwon et al. Page 16
Table 2
The area (mm2) of the descending thoracic luminal surface exposed time-averaged wall shear stress above the
threshold for platelet aggregation in vitro
Palmaz NumedCP GenesisXD
Area (mm2) in descending aorta with TAWSS above the threshold (mm2) 1880 2010 559
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